Oligomycin, an F1FO-ATPase Inhibitor, Protects Against Ischemic Acute Kidney Injury in Male but Not in Female Rats
We investigated the effects of oligomycin, an F1FO-ATPase inhibitor, on ischemic acute kidney injury in male and female rats. Ischemic acute kidney injury was induced by clamping the left renal artery and vein for 45 or 60 min followed by reperfusion, 2 weeks after contralateral nephrectomy. Renal d...
Saved in:
Main Authors: | Ryosuke Tanaka (Author), Junji Takayama (Author), Masanori Takaoka (Author), Yohko Sugino (Author), Mamoru Ohkita (Author), Yasuo Matsumura (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Discovery for Overcoming Chronic Kidney Disease (CKD): The Endothelin ETB Receptor / Nitric Oxide System Functions as a Protective Factor in CKD
by: Mamoru Ohkita, et al.
Published: (2009) -
Thioalbamide inhibits FoF1-ATPase in breast cancer cells and reduces tumor proliferation and invasiveness in breast cancer in vivo models
by: L. Frattaruolo, et al.
Published: (2023) -
Pharmacology in Health Foods: Improvement of Vascular Endothelial Function by French Maritime Pine Bark Extract (Flavangenol)
by: Mamoru Ohkita, et al.
Published: (2011) -
Reduced Mitochondrial Membrane Potential Is a Late Adaptation of Trypanosoma brucei brucei to Isometamidium Preceded by Mutations in the γ Subunit of the F1Fo-ATPase.
by: Anthonius A Eze, et al.
Published: (2016) -
Pathophysiological Roles of Endothelin Receptors in Cardiovascular Diseases
by: Mamoru Ohkita, et al.
Published: (2012)